Global Fatty Acid Oxidation Disorder Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Global Fatty Acid Oxidation Disorder Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Report Code: KNJ1028142 | No. of Pages: 129 | Category: Pharmaceuticals and Healthcare
Publisher: GRD Survey | Date of Publish: Nov-2021
Executive Summary

According to GRD Survey data, the global Fatty Acid Oxidation Disorder market was valued at  million US$ in 2020 and is expected to reach  million US$ by the end of 2027, growing at a CAGR of % in the forecast period between 2021 and 2027.

This report studies the Fatty Acid Oxidation Disorder market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Fatty Acid Oxidation Disorder in these regions, from 2016 to 2027, covering
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
    Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
    South America (Brazil, Argentina, Colombia, etc.)
    Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
    Oral

    Intravenous Injection

Market Snapshot, By Application
    Hospital pharmacies

    Retail pharmacies

    Drug stores

    Online stores

Main Market Players Analyzed in this report, including:
    Spectrum Chemical Manufacturing Corporation

    Sigma-Tau Pharmaceuticals

    Northeast Pharmaceutical Group

    Mylan Laboratories

    Merck KGaA

    Daiichi Sankyo

    Chengda Pharmaceuticals

    Biosynth AG

    Bedford Laboratories

    AminoScience


The study objectives of this report are:
    To study and analyze the global Fatty Acid Oxidation Disorder market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
    To understand industry structure of Fatty Acid Oxidation Disorder market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    To identify the key global Fatty Acid Oxidation Disorder manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Fatty Acid Oxidation Disorder market with respect to individual growth trends, future prospects, and their contribution to the total market.
    To project the value and volume of Fatty Acid Oxidation Disorder submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Fatty Acid Oxidation Disorder are as follows:
    History Year: 2016-2020
    Base Year: 2020
    Estimated Year: 2021
    Forecast Year 2021 to 2027

This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Contents

1  Market Definition & Scope
    1.1  Definition & Scope
    1.2 Fatty Acid Oxidation Disorder Product Specifications
    1.3  Main Events (Entry, M&A, Exit, Technology and Capital Activity)
    1.4 Global Fatty Acid Oxidation Disorder Market Performance and Outlook

2 Market Development Performance under COVID-19
    2.1 Influencing Factors of Industry Development in the Next Five Years
        2.1.1 Drivers
        2.1.2 Restraints
        2.1.3 Opportunities
    2.2 Porter’s Five Forces Analysis
    2.3 Comparison of Alternatives and Fatty Acid Oxidation Disorder

3 Supply Chain and Manufacturing Cost Analysis
    3.1 Supply Chain Analysis
    3.2 Raw Materials and Key Suppliers Analysis
        3.2.1 Raw Materials Introduction
        3.2.1 Raw Materials Key Suppliers List
    3.3 Fatty Acid Oxidation Disorder Sales Channel and Distributors Analysis
        3.3.1 Fatty Acid Oxidation Disorder Sales Channel
        3.3.2 Fatty Acid Oxidation Disorder Distributors
    3.4 Key Buying Industries/Consumers
        3.4.1 Major Buyers in Hospital pharmacies

        3.4.2 Major Buyers in Retail pharmacies

    3.5 Fatty Acid Oxidation Disorder Manufacturing Cost Structure Analysis

4 Market Segment: by Type
    4.1 Fatty Acid Oxidation Disorder Type Introduction
        4.1.1 Oral

        4.1.2 Intravenous Injection
    4.2 Global Fatty Acid Oxidation Disorder Sales by Type 2016-2021
    4.3 Global Fatty Acid Oxidation Disorder Revenue by Type 2016-2021
    4.4 Global Fatty Acid Oxidation Disorder Price by Type 2016-2021

5 Market Segment: by Application
    5.1 Fatty Acid Oxidation Disorder Type Introduction
        5.1.1 Hospital pharmacies

        5.1.2 Retail pharmacies

        5.1.3 Drug stores

        5.1.3 Online stores
    5.2 Global Fatty Acid Oxidation Disorder Sales by Application 2016-2021
    5.3 Global Fatty Acid Oxidation Disorder Revenue by Application 2016-2021
    5.4 Global Fatty Acid Oxidation Disorder Price by Application 2016-2021

6 Marke Segment: by Region
    6.1 Global Fatty Acid Oxidation Disorder Market by Region
        6.1.1 Global Fatty Acid Oxidation Disorder Sales by Regions
        6.1.2 Global Fatty Acid Oxidation Disorder Revenue by Regions
    6.2 North America Fatty Acid Oxidation Disorder Market 2016-2021
    6.3 Europe Fatty Acid Oxidation Disorder Market 2016-2021
    6.4 Asia Pacific Fatty Acid Oxidation Disorder Market 2016-2021
    6.5 South America Fatty Acid Oxidation Disorder Market 2016-2021
    6.6 Middle East and Africa Fatty Acid Oxidation Disorder Market 2016-2021

7 North America
    7.1 North America Fatty Acid Oxidation Disorder Market by Country 2016-2021
        7.1.1 North America Fatty Acid Oxidation Disorder Sales by Country
        7.1.2 North America Fatty Acid Oxidation Disorder Revenue by Country
    7.2 United States
    7.3 Canada
    7.4 Mexico

8 Europe
    8.1 Europe Fatty Acid Oxidation Disorder Market by Country 2016-2021
        8.1.1 Europe Fatty Acid Oxidation Disorder Sales by Country
        8.1.2 Europe Fatty Acid Oxidation Disorder Revenue by Country
    8.2 Germany
    8.3 France
    8.4 UK
    8.5 Italy
    8.6 Russia
    8.7 Spain

9 Asia Pacific
    9.1 Asia Pacific Fatty Acid Oxidation Disorder Market by Country 2016-2021
        9.1.1 Asia Pacific Fatty Acid Oxidation Disorder Sales by Country
        9.1.2 Asia Pacific Fatty Acid Oxidation Disorder Revenue by Country
    9.2 China
    9.3 Japan
    9.4 Korea
    9.5 Southeast Asia
    9.6 India
    9.7 Australia

10 South America
    10.1 South America Fatty Acid Oxidation Disorder Market by Country 2016-2021
        10.1.1 South America Fatty Acid Oxidation Disorder Sales by Country
        10.1.2 South America Fatty Acid Oxidation Disorder Revenue by Country
    10.2 Brazil
    10.3 Argentina
    10.4 Colombia

11 Middle East and Africa
    11.1 Middle East and Africa Fatty Acid Oxidation Disorder Market by Country 2016-2021
        11.1.1 Middle East and Africa Fatty Acid Oxidation Disorder Sales by Country
        11.1.2 Middle East and Africa Fatty Acid Oxidation Disorder Revenue by Country
    11.2 Turkey
    11.3 Saudi Arabia
    11.4 South Africa

12 Key Participants Company Information
    12.1 Spectrum Chemical Manufacturing Corporation

        12.1.1 Spectrum Chemical Manufacturing Corporation
 Company Information
        12.1.2 Spectrum Chemical Manufacturing Corporation
 Fatty Acid Oxidation Disorder Product Portfolio, Specification and Application
        12.1.3 Spectrum Chemical Manufacturing Corporation
 Fatty Acid Oxidation Disorder Sales, Price, Revenue and Gross Margin (2019-2021)
        12.1.4 Spectrum Chemical Manufacturing Corporation
 Key Development
    12.2 Sigma-Tau Pharmaceuticals

        12.2.1 Sigma-Tau Pharmaceuticals
 Company Information
        12.2.2 Sigma-Tau Pharmaceuticals
 Fatty Acid Oxidation Disorder Product Portfolio, Specification and Application
        12.2.3 Sigma-Tau Pharmaceuticals
 Fatty Acid Oxidation Disorder Sales, Price, Revenue and Gross Margin (2019-2021)
        12.2.4 Sigma-Tau Pharmaceuticals
 Key Development
    12.3 Northeast Pharmaceutical Group

        12.3.1 Northeast Pharmaceutical Group
 Company Information
        12.3.2 Northeast Pharmaceutical Group
 Fatty Acid Oxidation Disorder Product Portfolio, Specification and Application
        12.3.3 Northeast Pharmaceutical Group
 Fatty Acid Oxidation Disorder Sales, Price, Revenue and Gross Margin (2019-2021)
        12.3.4 Northeast Pharmaceutical Group
 Key Development
    12.4 Mylan Laboratories

        12.4.1 Mylan Laboratories
 Company Information
        12.4.2 Mylan Laboratories
 Fatty Acid Oxidation Disorder Product Portfolio, Specification and Application
        12.4.3 Mylan Laboratories
 Fatty Acid Oxidation Disorder Sales, Price, Revenue and Gross Margin (2019-2021)
        12.4.4 Mylan Laboratories
 Key Development
    12.5 Merck KGaA

        12.5.1 Merck KGaA
 Company Information
        12.5.2 Merck KGaA
 Fatty Acid Oxidation Disorder Product Portfolio, Specification and Application
        12.5.3 Merck KGaA
 Fatty Acid Oxidation Disorder Sales, Price, Revenue and Gross Margin (2019-2021)
        12.5.4 Merck KGaA
 Key Development
    12.6 Daiichi Sankyo

        12.6.1 Daiichi Sankyo
 Company Information
        12.6.2 Daiichi Sankyo
 Fatty Acid Oxidation Disorder Product Portfolio, Specification and Application
        12.6.3 Daiichi Sankyo
 Fatty Acid Oxidation Disorder Sales, Price, Revenue and Gross Margin (2019-2021)
        12.6.4 Daiichi Sankyo
 Key Development
    12.7 Chengda Pharmaceuticals

        12.7.1 Chengda Pharmaceuticals
 Company Information
        12.7.2 Chengda Pharmaceuticals
 Fatty Acid Oxidation Disorder Product Portfolio, Specification and Application
        12.7.3 Chengda Pharmaceuticals
 Fatty Acid Oxidation Disorder Sales, Price, Revenue and Gross Margin (2019-2021)
        12.7.4 Daiichi Sankyo
 Key Development
    12.9 Bedford Laboratories

        12.9.1 Bedford Laboratories
 Company Information
        12.9.2 Bedford Laboratories
 Fatty Acid Oxidation Disorder Product Portfolio, Specification and Application
        12.9.3 Bedford Laboratories
 Fatty Acid Oxidation Disorder Sales, Price, Revenue and Gross Margin (2019-2021)
        12.9.4 Bedford Laboratories
 Key Development
    12.8 Biosynth AG

        12.8.1 Biosynth AG
 Company Information
        12.8.2 Biosynth AG
 Fatty Acid Oxidation Disorder Product Portfolio, Specification and Application
        12.8.3 Biosynth AG
 Fatty Acid Oxidation Disorder Sales, Price, Revenue and Gross Margin (2019-2021)
        12.8.4 Biosynth AG
 Key Development

13 Global Fatty Acid Oxidation Disorder Market Forecast by Region by Type and by Application
    13.1 Global Fatty Acid Oxidation Disorder Sales, Revenue Forecast 2022-2027
    13.2 Global Fatty Acid Oxidation Disorder Forecast by Regions
        13.2.1 Global Fatty Acid Oxidation Disorder Sales Forecast by Region 2022-2027
        13.2.2 Global Fatty Acid Oxidation Disorder Revenue Forecast by Region 2022-2027
    13.3 Global Fatty Acid Oxidation Disorder Forecast by Type
        13.3.1 Global Fatty Acid Oxidation Disorder Sales Forecast by Type 2022-2027
        13.3.2 Global Fatty Acid Oxidation Disorder Revenue Forecast by Type 2022-2027
        13.3.3 Global Fatty Acid Oxidation Disorder Price Forecast by Type 2022-2027
    13.4 Global Fatty Acid Oxidation Disorder Forecast by Application
        13.4.1 Global Fatty Acid Oxidation Disorder Sales Forecast by Application 2022-2027
        13.4.2 Global Fatty Acid Oxidation Disorder Revenue Forecast by Application 2022-2027
        13.4.3 Global Fatty Acid Oxidation Disorder Price Forecast by Application 2022-2027

14 Analyst Views and Conclusions

15 Methodology and Data Source
    15.1 Methodology
    15.2 Research Data Source
        15.2.1 Secondary Data
        15.2.2 Primary Data
        15.2.3 Market Size Estimation
    15.3 Legal Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com